A Novel Mutation of the Spectrin Gene

NCT00723567 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2009-02-19

No results posted yet for this study

Summary

The purpose of this study is to find a gene or its mutation (an altered gene) that puts individuals at risk for developing HE or HPP.

Conditions

  • Hereditary Elliptocytosis (HE)
  • Hereditary Pyropoikilocytosis (HPP)

Sponsors & Collaborators

  • University of Witwatersrand, South Africa

    collaborator OTHER
  • University of Utah

    lead OTHER

Principal Investigators

  • Josef T Prchal, MD · University of Utah

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00723567 on ClinicalTrials.gov